Showing results (21-30 of 398) with videos related to
Sort By:
Pageof 40
Molecules and Cells|September 13, 2024
Linkage of alternative exon assembly in Drosophila TrpA1 transcriptsEun Jo Du, MinHyuk Lee, Seon Yeong Kim, et al.Cancer Research and Treatment|November 18, 2021
Genomic Sequencing for Bladder Urothelial Carcinoma and Its Clinical Implications for ImmunotherapyRyul Kim, Jung Yong Hong, Jeeyun Lee, et al.Cancer Chemotherapy and Pharmacology|August 11, 2007
A randomized trial of anemia correction with two different hemoglobin targets in the first-line chemotherapy of advanced gastric cancerSe Hoon Park, Eunmi Nam, Soo-Mee Bang, et al.Pathology, Research and Practice|December 1, 2022
Five-gene signature for the prediction of response to immune checkpoint inhibitors in patients with gastric and urothelial carcinomasSo Young Kang, You Jeong Heo, Ghee Young Kwon, et al.Journal of Nanoscience and Nanotechnology|July 7, 2021
Printed Electrode for High-Performance Bow-Tie Antenna by Photonic Sintering ProcessHyun Jin Nam, Ji-Hun Yuk, Kyu Song, et al.Materials (Basel, Switzerland)|March 28, 2024
Physical Properties of Paste Synthesized from Wet- and Dry-Processed Silver PowdersHyun Jin Nam, Minkyung Shin, Hye Young Koo, et al.BMC Cancer|October 16, 2015
Capecitabine in combination with either cisplatin or weekly paclitaxel as a first-line treatment for metastatic esophageal squamous cell carcinoma: a randomized phase II studySu Jin Lee, Sungmin Kim, Moonjin Kim, et al.BMC Microbiology|April 19, 2015
Comparative analysis of gut microbiota in elderly people of urbanized towns and longevity villagesSe-Hoon Park, Kyung-Ah Kim, Young-Tae Ahn, et al.BMC Urology|August 4, 2016
A Korean multi-center, real-world, retrospective study of first-line pazopanib in unselected patients with metastatic renal clear-cell carcinomaMoon Jin Kim, Se Hoon Park, Jae-Lyun Lee, et al.BMC Cancer|February 23, 2005
Docetaxel plus cisplatin is effective for patients with metastatic breast cancer resistant to previous anthracycline treatment: a phase II clinical trialSe Hoon Park, Eun Kyung Cho, Soo-Mee Bang, et al.Pageof 40